Therapeutic options in the treatment of benign prostatic hyperplasia

Abstract

Current theraputic options for the treatment of symptomatic benign prostatic hyperplasia (BPH) are reviewed. Therapeutic options for mild lower urinary tract symptoms (LUTS), as defined by the American Urological Association, are generally treated medically. Moderate to severe LUTS can be treated medically or with surgical therapy. Current medical and surgical treatments for LUTS secondary to BPH are reviewed and evolving treatments are explored.

Successful treatment of complicated benign prostatic hyperplasia in a diabetic patient with water vapor thermal therapy and urethral stenting

“…With pharmacotherapy, patients often commit to a lifetime of adherence, along with adverse effects such as retrograde ejaculation and orthostatic hypotension, along with less-than-optimal improvement. Studies indicate that Terazosin, a commonly prescribed alpha-antagonist for BPH, can improve one's AUASS by 6 points after 1 year with the uroselective Tamsulosin demonstrating a similar efficacy 3 . This is in comparison to the immediate 29-point decrease observed in our patient treated with WVTT.…”

Rezum: a novel transurethral water vapor therapy for benign prostatic hyperplasia

“…However, these risks are relatively uncommon and can usually be managed with medication. In a review10 the incidence of complications ranged from 3.8% to 4.3%, all of which were mild and resolved on their own. In addition, the success rate of voiding trials following Rezum therapy was 85%10.…”

“…In a review10 the incidence of complications ranged from 3.8% to 4.3%, all of which were mild and resolved on their own. In addition, the success rate of voiding trials following Rezum therapy was 85%10. In addition, the procedure has a lower incidence of sexual side effects compared with other treatments.…”